Regeneron Pharmaceuticals: money & deals
Regeneron Pharmaceuticals' timeline holds 505 money & deals claims from 2007 to 2026. The latest took effect on .
Newest first, 20 years; a claim a later one replaced stays on the line, struck through. Current state →
Facts: CEO · CFO · headquarters · revenue · net income · operating income · quarterly revenue · across every company: ceos, cfos, headquarters, revenue, net income, quarterly revenue
· 7
- sec.gov, 1 source, claim clm_5EBA4C72A92Fcash and equivalents 3,659,100,000 United States dollar
- sec.gov, 1 source, claim clm_DEF587D6916Aquarterly net income 1,948,700,000 United States dollar
- sec.gov, 1 source, claim clm_4585DB96888Dquarterly operating income 2,048,200,000 United States dollar
- sec.gov, 1 source, claim clm_4D8C13296D0Aquarterly research and development 1,794,700,000 United States dollar
- sec.gov, 1 source, claim clm_15BDC7B1496Equarterly revenue 5,115,800,000 United States dollar
- sec.gov, 1 source, claim clm_F46BE3EF6472total assets 44,405,200,000 United States dollar
- sec.gov, 1 source, claim clm_24A29A7153C0total equity 33,498,500,000 United States dollar
· 7
- to sec.gov, 1 source, claim clm_6D7C70396974cash and equivalents 2,455,800,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_6178480D55DFquarterly net income 1,296,900,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_2721EF4559B5quarterly operating income 1,293,500,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_223E08E3A074quarterly research and development 1,631,600,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_11098E7F99BCquarterly revenue 4,290,700,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_0A911086D51Btotal assets 41,730,600,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_B9E0E558C863total equity 31,711,400,000 United States dollar (replaced)
· 7
- to sec.gov, 1 source, claim clm_518E1E5FF285cash and equivalents 2,962,600,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_55728063B1D6quarterly net income 727,200,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_6BF4C3658A74quarterly operating income 642,900,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_D76E4D0088C5quarterly research and development 1,543,500,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_89291214D4AAquarterly revenue 3,605,400,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_81C2322B5ECEtotal assets 40,868,800,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_98A5851FED3Ctotal equity 31,423,600,000 United States dollar (replaced)
· 7
- to sec.gov, 1 source, claim clm_B18C1963BC40cash and equivalents 3,118,100,000 United States dollar (replaced)
- sec.gov, 1 source, claim clm_7514724ED5E9net income 4,504,900,000 United States dollar
- sec.gov, 1 source, claim clm_1B456AFB0CC5operating income 3,577,900,000 United States dollar
- sec.gov, 1 source, claim clm_1819F20C7CC4research and development 5,850,200,000 United States dollar
- sec.gov, 1 source, claim clm_E5421E95D3E6revenue 14,342,900,000 United States dollar
- to sec.gov, 1 source, claim clm_CFD74D844717total assets 40,558,700,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_68C522C0BDEDtotal equity 31,256,900,000 United States dollar (replaced)
· 7
- to sec.gov, 1 source, claim clm_5CC511D1F933cash and equivalents 2,506,400,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_75B9586D5FEEquarterly net income 1,460,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_0F41A2F44A01quarterly operating income 1,026,800,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_F00F9DA4362Cquarterly research and development 1,475,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_471EC2DBAE0Bquarterly revenue 3,754,300,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_A47C41C5A48Ctotal assets 40,169,400,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_CF9BA729AF1Etotal equity 30,957,800,000 United States dollar (replaced)
· 7
- to sec.gov, 1 source, claim clm_436CC0AE1280cash and equivalents 1,995,800,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_80007FEE76CEquarterly net income 1,391,600,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_0CA4006DEF0Cquarterly operating income 1,079,500,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_7D676D307920quarterly research and development 1,421,700,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_43E679905BB9quarterly revenue 3,675,600,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_0BB82D220F7Etotal assets 38,219,200,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_4D236E01F288total equity 29,938,900,000 United States dollar (replaced)
· 7
- to sec.gov, 1 source, claim clm_775D46B7A29Fcash and equivalents 3,090,200,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_65FFF2CBF333quarterly net income 808,700,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_3F78C327F519quarterly operating income 591,700,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_4BF4BD70527Equarterly research and development 1,327,400,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_04C1A63A27E9quarterly revenue 3,028,700,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_DADAA2FC572Etotal assets 37,545,200,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_B1CBF863516Btotal equity 29,387,600,000 United States dollar (replaced)
· 7
- to sec.gov, 1 source, claim clm_F0F5921A0058cash and equivalents 2,488,200,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_4E27594C511Anet income 4,412,600,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_398CD3D76930operating income 3,990,700,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_C301E7CAF361research and development 5,132,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_EE95AAD2339Erevenue 14,202,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_428AF772B422total assets 37,759,400,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_3F5BAE27E768total equity 29,353,600,000 United States dollar (replaced)
· 7
- to sec.gov, 1 source, claim clm_616C3B8DE457cash and equivalents 2,011,800,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_B2193D668623quarterly net income 1,340,600,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_EB508637D538quarterly operating income 1,179,500,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_61BE04D629BBquarterly research and development 1,271,500,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_A6AD04E866B3quarterly revenue 3,720,700,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_58CF60C9C3BBtotal assets 37,441,900,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_F515E2AB009Dtotal equity 29,325,900,000 United States dollar (replaced)
· 7
- to sec.gov, 1 source, claim clm_B12373EE7B0Ccash and equivalents 1,920,700,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_01E985023556quarterly net income 1,432,300,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_9B13454F52AAquarterly operating income 1,069,600,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_6410B4B55A22quarterly research and development 1,200,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_3891C0E928C4quarterly revenue 3,547,100,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_567F86365DD5total assets 36,086,800,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_E2B4233513FCtotal equity 28,205,800,000 United States dollar (replaced)
· 7
- to sec.gov, 1 source, claim clm_BB705899FBD2cash and equivalents 2,602,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_D6451915A936quarterly net income 722,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_5DA47B349189quarterly operating income 751,400,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_833AAF046462quarterly research and development 1,248,400,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_A39660FD9A27quarterly revenue 3,145,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_89235EAA3408total assets 34,369,600,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_792E7538AC26total equity 26,991,100,000 United States dollar (replaced)
· 7
- to sec.gov, 1 source, claim clm_65E6ADFD0D80cash and equivalents 2,730,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_11400CA0B8A6net income 3,953,600,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_5B0035249BB7operating income 4,047,100,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_5546754D63D6research and development 4,439,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_0A05777F6B3Arevenue 13,117,200,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_24DDC4DBA718total assets 33,080,200,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_FF328F070B8Btotal equity 25,973,100,000 United States dollar (replaced)
· 7
- to sec.gov, 1 source, claim clm_FD93D07E05CDcash and equivalents 2,152,300,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_0089CAC97396quarterly net income 1,007,800,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_D79F18FC7528quarterly operating income 1,111,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_5C3B864B89C2quarterly research and development 1,075,300,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_D14890ED012Fquarterly revenue 3,362,700,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_924A6CAD98A4total assets 32,163,300,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_426EFFDCB275total equity 24,904,400,000 United States dollar (replaced)
· 7
- to sec.gov, 1 source, claim clm_F903F28AA80Fcash and equivalents 1,937,200,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_0598850A1A59quarterly net income 968,400,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_0742E18258B7quarterly operating income 1,016,500,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_7BB6A57A5F50quarterly research and development 1,085,300,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_03FC6245728Fquarterly revenue 3,158,100,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_4CC63E98652Atotal assets 30,657,500,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_C2064E6D19CFtotal equity 24,017,900,000 United States dollar (replaced)
· 7
- to sec.gov, 1 source, claim clm_7E7BB784381Acash and equivalents 3,916,300,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_802196BED548quarterly net income 817,800,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_D8EB51091FB4quarterly operating income 946,700,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_7DFE5AEE2C50quarterly research and development 1,101,200,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_179FAEBC31F3quarterly revenue 3,162,100,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_0963A3E9D139total assets 30,059,900,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_E4AE0A080B44total equity 23,495,200,000 United States dollar (replaced)
/timelines/regeneron-pharmaceuticals.md?kind=money/v1/timelines/regeneron-pharmaceuticals?kind=money